Accendra Health (NYSE:ACH) Posts Earnings Results, Misses Expectations By $0.18 EPS

Accendra Health (NYSE:ACH) announced its quarterly earnings results on Thursday. The company reported ($0.23) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.18), FiscalAI reports. The company had revenue of $601.77 million during the quarter. Accendra Health had a negative return on equity of 4.02% and a negative net margin of 11.41%.

Accendra Health Stock Performance

Shares of ACH stock traded down $0.10 during mid-day trading on Friday, hitting $0.20. 2,897,555 shares of the stock traded hands, compared to its average volume of 3,868,586. Accendra Health has a twelve month low of $0.19 and a twelve month high of $4.69. The company’s 50-day simple moving average is $0.62 and its 200-day simple moving average is $2.12. The firm has a market cap of $15.51 million, a price-to-earnings ratio of -0.09 and a beta of 1.60.

Analyst Ratings Changes

Several equities analysts have recently issued reports on ACH shares. Citigroup downgraded shares of Accendra Health from a “buy” rating to a “neutral” rating and reduced their price target for the company from $4.50 to $1.50 in a report on Monday, August 10th. UBS Group reduced their target price on shares of Accendra Health from $4.50 to $1.50 and set a “neutral” rating for the company in a research note on Thursday, August 13th. Robert W. Baird cut shares of Accendra Health from an “outperform” rating to a “neutral” rating and set a $1.50 target price for the company. in a research report on Tuesday, August 11th. Zacks Research upgraded shares of Accendra Health from a “strong sell” rating to a “hold” rating in a research note on Tuesday. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Accendra Health in a report on Tuesday. Four investment analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Reduce” and an average price target of $1.50.

Institutional Trading of Accendra Health

Several institutional investors have recently modified their holdings of the company. BlackRock Inc. acquired a new position in Accendra Health during the second quarter worth about $18,824,000. Bank of America Corp DE bought a new stake in Accendra Health in the second quarter worth about $12,912,000. Paradigm Capital Management Inc. NY bought a new stake in Accendra Health in the second quarter worth about $8,676,000. Dimensional Fund Advisors LP acquired a new stake in Accendra Health in the 1st quarter valued at about $5,943,000. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new stake in Accendra Health in the 2nd quarter valued at about $4,408,000.

About Accendra Health

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services.